Article Details
Retrieved on: 2024-09-02 00:22:38
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
iX Biopharma Ltd. (SG:42C) has released an update. iX Biopharma Ltd has revealed a pharmacokinetic study indicating that their SL-NAD+ wafer can ...
Article found on: www.tipranks.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here